Rethinking generics

  • A Fast Growing Pharmaceuticals Company

    Alvogen is a multinational, privately-owned pharmaceuticals company, focused on complex generic pharmaceutical products. With offices in over 20 countries, Alvogen has a portfolio of over 200 strategically selected projects.

  • Building young lives in Sierra Leone

    From education and community development to health, the Alvogen family is committed to helping young people build a brighter future. Alvogen employees around the world have reached out to family, friends and business partners whose generosity will allow us in turn to reach out to thousands of children in Somalia who have been affected by drought and famine

  • Supporting future science

    As a second generation generics company, Alvogen is focused on new science and technology benefitting future generations of young people. In one of our social responsibility initatives, Alvogen has teamed up with Colombia University and a group of distinguished scientists from all over the world representing different academic disciplines.

  • Dynamic Culture

    Alvogen is not a conventional company, and we don’t intend to become one. We are not afraid to follow an unbeaten path in our efforts to differentiate, provide innovative solutions to our customers and drive our business forward. We are change-driven, innovative and passionate in meeting the challenges in our industry.

Fit for Growth
Products
Our Impact
Partnership
Join Us

Fit for growth

Alvogen is a multinational pharmaceuticals company focused on complex generic products

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on complex generic pharmaceutical products. The company is committed to building the next-generation generics company through the strategic selection of products, partners and markets, and the utilization of an effective consolidated global supply chain. Robert Wessman is the Chairman and CEO of Alvogen and leads its global expansion. Alvogen’s headquarters are in Pine Brook, New Jersey.

View Company Profile

  • News
  • Blog
  • Alvogen in the News
Alvogen launches introduces Vancomycin in the U.S. market
10.4.2012

Alvogen today announced the introduction of Vancomycin Hydrochloride Capsules, USP, an antibacterial indicated to treat infections that include C. difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus. 

meira
The Game
1.3.2012 Robert Wessman

Our playing field is the international generic industry. This is an industry with vast untapped potential, both geographically and technically, as generic pharmaceuticals become available in more markets and new difficult-to-make formulations are added to the generic portfolio. The industry is recession resistant by nature and is an answer to rising healthcare costs and ongoing need to improve the efficiency of healthcare systems around the world.

meira
Alvogen launches new generics in Romania – Pharmaletter
19.8.2011

Link to the full article

meira
We are not
afraid to follow
an unbeaten
path

Products

Fast growing product portfolio

We focus on difficult-to-make and high-value formulations and pursue first-to-file opportunities. With more than 200 pharmaceutical projects in development and registration, over 100 product and market launches are expected in 2012.

Our product pipeline is filled by selections from internal R&D candidates, in-licensed products, fostering strategic partnerships and targeted portfolio acquisitions and consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology.

Learn more


Featured Products

We focus on
difficult-to-make
and high-value
formulations

Our Impact

Building young lives in Sierra Leone

Over the next three years, Alvogen in Africa will sponsor the education and vocational training of youths in Sierra Leone.

At the center supported by Alvogen, young people directly affected by the civil war will have the opportunity to learn a particular trade, and will be supplied with the necessary equipment to complete this training.

Learn more

Together
we can
make a
difference

Partnerships

Alvogen is Open for Collaborations

Collaboration with other companies in our industry, academia, government and non-governmental organizations is fundamental to our strategic priorities of growing a diversified, global business and delivering a wide range of valuable products.

At Alvogen, we value partnerships and collaboration. Our future strategy relies heavily on strategic selection of people and successful partnerships around the world. We believe that by working together, we can discover, develop, and deliver the best value for our customers.

Learn more

We seek the
best capabilities
available,
whatever the
source

Join Us

Say hello to Fun!

Alvogen is not a conventional company and we don’t intent to become one. We are not afraid to follow an unbeaten path in our efforts to differentiate, provide innovative solutions to our customers and drive our business forward.

We are
energetic and
creative, always
seeking
to improve

You

  • Have a big heart
  • Innovative and street-smart
  • Passionate to make a difference
  • Willing to walk the extra mile to succeed
  • Care deeply about producing the highest quality work
  • Think it's cool to set new standards and be a part of a winning team
  • Work well with others

We

  • Are looking for talented people
  • Foster an environment where people can flourish and achieve their full potential
  • Are not afraid to follow an unbeaten path in our efforts to continuously do better
  • Encourage and reward innovative thinking
  • Are on an exciting journey to create the next generation generics company
  • Work hard and expect the same from you
  • Want you to be the best you can be
  • Would be happy to answer any questions

Learn more